{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":45,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":45,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"817cea60e012","filters":{"venue":"Expert Opinion on Emerging Drugs"}},"results":[{"id":"W2127246176","doi":"10.1517/14728214.12.1.113","title":"Emerging drugs in neuropathic pain","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Queen's University","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Medicine; Neuropathic pain; Pharmacology; Chronic pain; Adverse effect; Clinical trial; Population; Intensive care medicine; Bioinformatics; Psychiatry; Internal medicine","authors":[{"name":"Ian Gilron","is_ca":true},{"name":"Terence J. Coderre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05585911933335879,"gpt":0.390085177091625,"spread":0.3342260577582662,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015214,0.001290359,0.001847279,0.003074044,0.0004522859,0.00121465,0.001139179,0.002255159,0.008894423],"category_scores_gemma":[0.00069513,0.0003294086,0.0006790183,0.003238076,0.0008157176,0.002478449,0.0008571045,0.003018766,0.006304786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009739125,"about_ca_system_score_gemma":0.001260066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001074519,"about_ca_topic_score_gemma":0.002712932,"domain_scores_codex":[0.9995742,0.00007923345,0.00004533345,0.00006781748,0.0001943175,0.00003906929],"domain_scores_gemma":[0.999536,0.0001821432,0.00006675123,0.00002365265,0.0001416033,0.00004990138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007605679,0.0001316212,0.0001285863,0.009295185,0.00005911188,0.000543577,0.00008378336,0.0002747965,0.002655733,0.006999401,0.03915518,0.940597],"study_design_scores_gemma":[0.00003670188,0.0001110438,0.0004080041,0.001631778,0.0000399112,0.001717729,0.00004853754,0.00008101886,0.000494191,0.00251854,0.9928988,0.00001375474],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000150934,0.995133,0.000262642,0.0006281068,0.0006471378,0.00001413926,0.00001453745,0.00001176365,0.003137684],"genre_scores_gemma":[0.0008093013,0.9946308,0.000581263,0.0008948343,0.000622986,0.00001686056,0.00003729701,0.000002550736,0.002404112],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008894423,"threshold_uncertainty_score":0.02975476,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009384447","doi":"10.1517/14728214.2014.915025","title":"Emerging drugs for neuropathic pain","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Medicine; Neuropathic pain; Gabapentin; Intensive care medicine; Pharmacology; Alternative medicine","authors":[{"name":"Ian Gilron","is_ca":true},{"name":"Anthony H. Dickenson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04484334409380448,"gpt":0.3797579390529872,"spread":0.3349145949591827,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006173062,0.001071388,0.001446176,0.002470846,0.0002809303,0.0009966651,0.0008972039,0.001395735,0.01391806],"category_scores_gemma":[0.0007585081,0.000227068,0.0009237407,0.001962197,0.0004622641,0.001262478,0.0008268786,0.002374984,0.005567432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007763751,"about_ca_system_score_gemma":0.001402056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001114598,"about_ca_topic_score_gemma":0.002313189,"domain_scores_codex":[0.9996421,0.00006792339,0.00004225515,0.00005270868,0.0001568869,0.0000380104],"domain_scores_gemma":[0.9996659,0.0001224752,0.00006866808,0.000013559,0.00009972756,0.00002974044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006472332,0.00005971913,0.00007677008,0.02570062,0.0001310085,0.000183387,0.00005180231,0.0001968086,0.001752036,0.00490494,0.04433853,0.9225397],"study_design_scores_gemma":[0.00003527181,0.00007768546,0.0003906178,0.006975525,0.0001401107,0.0009209502,0.0000323287,0.0000707766,0.0003735072,0.002080087,0.9888896,0.00001357196],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001171905,0.9959214,0.000231427,0.0006210268,0.00047396,0.00002261435,0.0000521951,0.00001868001,0.002541652],"genre_scores_gemma":[0.001009746,0.9957722,0.0003678692,0.0006467342,0.0002631541,0.00001917343,0.00008296027,0.000002764506,0.001835327],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01391806,"threshold_uncertainty_score":0.04656059,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035771416","doi":"10.1517/14728214.13.1.63","title":"Emerging drugs for spinal cord injury","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Krembil Foundation; University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Neuroprotection; Clinical trial; Spinal cord injury; Neuroscience; Bioinformatics; Intensive care medicine; Pharmacology; Spinal cord; Pathology; Biology","authors":[{"name":"Darryl C. Baptiste","is_ca":true},{"name":"Michael G. Fehlings","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1231186783573547,"gpt":0.4933757197572663,"spread":0.3702570413999116,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005011779,0.001222823,0.001275631,0.002268253,0.0003530917,0.0009809223,0.0007868148,0.001628381,0.01375307],"category_scores_gemma":[0.000394191,0.0002442165,0.0005766406,0.001590637,0.0004231115,0.001373549,0.0007692222,0.002134454,0.008416116],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000696016,"about_ca_system_score_gemma":0.00143815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009871183,"about_ca_topic_score_gemma":0.002348742,"domain_scores_codex":[0.9997706,0.00003809476,0.00002713391,0.00003214362,0.0001069247,0.00002505007],"domain_scores_gemma":[0.9998094,0.00004667698,0.00003992939,0.000009445357,0.00007016079,0.00002436595],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008262089,0.0001353058,0.00008230647,0.009964576,0.00007889073,0.0004110243,0.00006198012,0.000202204,0.00490337,0.00599844,0.04123641,0.9368427],"study_design_scores_gemma":[0.00005575743,0.0001342113,0.0003334298,0.002103548,0.000068311,0.00119733,0.00003559217,0.00007623675,0.0008197864,0.002179245,0.9929853,0.00001112107],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002176398,0.9929048,0.0003502734,0.0009428173,0.0006204689,0.00003229098,0.00003782598,0.00002444712,0.004869381],"genre_scores_gemma":[0.001302859,0.9918289,0.0009817539,0.0008373652,0.0004365002,0.00004368412,0.00008947693,0.00000347238,0.004476004],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01375307,"threshold_uncertainty_score":0.04600859,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026842455","doi":"10.1517/14728214.2012.667800","title":"Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Acute respiratory distress; Disease; Clinical trial; Psychological intervention; Lung; Internal medicine; Psychiatry","authors":[{"name":"Cory Yamashita","is_ca":true},{"name":"James F. Lewis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02716428527604438,"gpt":0.3393547807953631,"spread":0.3121904955193188,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001260075,0.0007870739,0.001366219,0.0006104565,0.0009007315,0.001397902,0.0009802749,0.01196966,0.004852655],"category_scores_gemma":[0.0045037,0.0002842812,0.0008773191,0.0004793228,0.00138495,0.002145919,0.0007690533,0.014283,0.00718416],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001611452,"about_ca_system_score_gemma":0.0009517351,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004685663,"about_ca_topic_score_gemma":0.001661465,"domain_scores_codex":[0.9988814,0.000323598,0.000147362,0.0001520869,0.0004008003,0.00009467558],"domain_scores_gemma":[0.9983066,0.0009524394,0.0001585479,0.0000531305,0.0003966025,0.0001326113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003441496,0.0001774736,0.0005145296,0.001466852,0.00006638305,0.008011828,0.0001338736,0.0002962975,0.002569407,0.0105193,0.7317446,0.2441553],"study_design_scores_gemma":[0.0002300389,0.0001991949,0.0005337493,0.0005497069,0.00003693569,0.006191246,0.00007596746,0.0003077427,0.0005958615,0.007231859,0.9840198,0.0000278839],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001134727,0.266145,0.001404371,0.6380606,0.07968631,0.000100574,0.0001086413,0.0001029063,0.01325683],"genre_scores_gemma":[0.01551292,0.2623482,0.003636803,0.5229661,0.1716531,0.0002298997,0.0001445376,0.00004779977,0.02346061],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01196966,"threshold_uncertainty_score":0.01623374,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4236574143","doi":"10.1517/14728214.12.3.461","title":"Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome","year":2007,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"National Institutes of Health","keywords":"Medicine; ARDS; Intensive care medicine; Population; Hypoxemia; Diffuse alveolar damage; Lung; Acute respiratory distress; Internal medicine","authors":[{"name":"Karen J. Bosma","is_ca":true},{"name":"James F. Lewis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02205253104450727,"gpt":0.3533447243498627,"spread":0.3312921933053554,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007330194,0.0005525526,0.0009754382,0.0007530962,0.0002499953,0.0005227001,0.0006947704,0.001351194,0.006845194],"category_scores_gemma":[0.0005900009,0.0001065943,0.0005451555,0.0003857419,0.0003631406,0.0008393252,0.0004379516,0.002081642,0.002523755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000354467,"about_ca_system_score_gemma":0.0004681759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002553728,"about_ca_topic_score_gemma":0.0009154502,"domain_scores_codex":[0.9997012,0.00009791018,0.00002750665,0.00002772934,0.0001079301,0.00003767376],"domain_scores_gemma":[0.9996997,0.00009501338,0.00005792408,0.0000121692,0.0000996275,0.0000355406],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006536893,0.0006242841,0.0006798153,0.003662203,0.0001820371,0.001577811,0.0001088656,0.0004028095,0.01354741,0.01128596,0.04423675,0.9230384],"study_design_scores_gemma":[0.001407358,0.001969446,0.002925668,0.001703248,0.0003085881,0.006629506,0.0001664893,0.0008952693,0.00533113,0.01050711,0.968115,0.00004108253],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004631594,0.9612982,0.004779961,0.01321543,0.002442779,0.00009388719,0.00007397159,0.00007451807,0.01338963],"genre_scores_gemma":[0.03352825,0.9281334,0.01499795,0.007892601,0.004048922,0.0002132898,0.0002910681,0.0000204623,0.01087406],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006845194,"threshold_uncertainty_score":0.02289951,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068824007","doi":"10.1517/14728214.2013.801453","title":"Emerging anti-inflammatory drugs for atherosclerosis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Inflammation; Intensive care medicine; Pharmacology; Internal medicine","authors":[{"name":"Jeremy Berman","is_ca":false},{"name":"Michael E. Farkouh","is_ca":true},{"name":"Robert S. Rosenson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03811104574974039,"gpt":0.321154783409983,"spread":0.2830437376602427,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006157362,0.001010469,0.00128008,0.002013382,0.0002981375,0.0009288653,0.0008272818,0.00137643,0.009804867],"category_scores_gemma":[0.0007064813,0.0002394603,0.0006412673,0.001699307,0.0004343435,0.001256625,0.0007284349,0.002702617,0.007408818],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006543248,"about_ca_system_score_gemma":0.001078003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007608573,"about_ca_topic_score_gemma":0.001716229,"domain_scores_codex":[0.9996855,0.00005249846,0.00003404152,0.0000448931,0.0001499033,0.00003311346],"domain_scores_gemma":[0.9996485,0.00009351423,0.00006280572,0.00001411392,0.0001396215,0.00004142026],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007334126,0.00007989299,0.00009169302,0.009789454,0.00007195441,0.0002115701,0.00003821973,0.0002001937,0.002643177,0.003471039,0.07578341,0.907546],"study_design_scores_gemma":[0.00002534789,0.00006298823,0.0002719391,0.001773608,0.0000481369,0.0007094247,0.00001661414,0.0000605077,0.0003336125,0.001057854,0.9956304,0.000009651005],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001354531,0.9946407,0.0002912283,0.0009110272,0.0009771598,0.00002067963,0.00004458356,0.00002454043,0.002954712],"genre_scores_gemma":[0.001037611,0.9938349,0.0005116564,0.0008664144,0.0006965435,0.00002103967,0.00009200755,0.000004208118,0.002935615],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009804867,"threshold_uncertainty_score":0.03280056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019078592","doi":"10.1517/14728210802568764","title":"Emerging tocolytics: challenges in designing and testing drugs to delay preterm delivery and prolong pregnancy","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"","keywords":"Medicine; Preterm delivery; Pregnancy; Intensive care medicine; Obstetrics; Pharmacology; Gestation","authors":[{"name":"David M. Olson","is_ca":true},{"name":"Inge Christiaens","is_ca":true},{"name":"Sara Gracie","is_ca":true},{"name":"Yuka Yamamoto","is_ca":true},{"name":"B.F. Mitchell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08815268921509375,"gpt":0.3536720905677467,"spread":0.265519401352653,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002996314,0.001062059,0.003312642,0.001904203,0.000400412,0.001625693,0.001971961,0.003101197,0.003378979],"category_scores_gemma":[0.002614016,0.0004633779,0.0007855612,0.001998963,0.0007372388,0.003078122,0.0006388595,0.002625579,0.002652357],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001200519,"about_ca_system_score_gemma":0.002678485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002088173,"about_ca_topic_score_gemma":0.005176564,"domain_scores_codex":[0.9990655,0.0002261773,0.000133626,0.0001004028,0.000416576,0.00005770743],"domain_scores_gemma":[0.9979558,0.0009672647,0.0002454188,0.00004686562,0.0006852072,0.00009943219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000100856,0.00009587488,0.0001889755,0.01596635,0.00008867915,0.0004247528,0.00007869953,0.0004018486,0.001979799,0.002957494,0.02837624,0.9493403],"study_design_scores_gemma":[0.0001215857,0.0003582932,0.0008947597,0.0094836,0.0002549484,0.001907615,0.0001974693,0.0003694659,0.001082369,0.003457964,0.9818308,0.00004104433],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002023072,0.9958193,0.0004018413,0.001950073,0.0003602907,0.00001670468,0.00002508827,0.00001174998,0.001212572],"genre_scores_gemma":[0.0008595198,0.9956291,0.001363933,0.000948817,0.0003536982,0.00002652539,0.00003673831,0.000002646716,0.0007791399],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003378979,"threshold_uncertainty_score":0.01584619,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2092130790","doi":"10.1517/14728214.2010.517746","title":"Emerging therapies for cystic fibrosis lung disease","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Cystic fibrosis; Mucociliary clearance; Medicine; Chloride channel; Airway; Lung; Cystic fibrosis transmembrane conductance regulator; Fibrosis; Respiratory system; Lung disease; Ion channel; Pathology; Internal medicine; Receptor; Cell biology; Anesthesia; Biology","authors":[{"name":"Hartmut Grasemann","is_ca":true},{"name":"Félix Ratjen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03499504691110344,"gpt":0.4096748499475913,"spread":0.3746798030364878,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006029705,0.0009589868,0.001129295,0.001640836,0.0003136742,0.0007096945,0.000687138,0.001500844,0.007544317],"category_scores_gemma":[0.000534239,0.0001777575,0.0005144473,0.001165366,0.0004272839,0.001343564,0.000683252,0.002572661,0.004998344],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000623774,"about_ca_system_score_gemma":0.0008739209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006767623,"about_ca_topic_score_gemma":0.001642797,"domain_scores_codex":[0.9997491,0.00004554177,0.0000241297,0.00003115397,0.0001288131,0.00002126239],"domain_scores_gemma":[0.9997736,0.00008266656,0.00003034568,0.000009284267,0.00007478707,0.00002927646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000691015,0.0001005367,0.00009621015,0.007379746,0.0000658151,0.0003411693,0.00006547642,0.0002333606,0.003281658,0.005135344,0.07592572,0.9073059],"study_design_scores_gemma":[0.00003196561,0.00007434098,0.0003321272,0.00182001,0.00004447017,0.0009446096,0.00003627882,0.00006274794,0.0003218191,0.001786318,0.9945363,0.000009151176],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001352571,0.9944465,0.0002742585,0.001222803,0.0008384814,0.00001446911,0.00002251193,0.00001677395,0.003028985],"genre_scores_gemma":[0.0006909684,0.9946018,0.0006370457,0.0009505365,0.0005553546,0.00001724387,0.00004718218,0.000002830996,0.002497085],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007544317,"threshold_uncertainty_score":0.02523822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006321561","doi":"10.1517/14728210903107751","title":"Emerging drugs for major depressive disorder","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Agomelatine; Antidepressant; Monoamine neurotransmitter; Medicine; Norepinephrine; Dopamine; Serotonin; Pharmacology; Duloxetine; Melatonin; Neuroscience; Psychiatry; Receptor; Internal medicine; Psychology; Anxiety","authors":[{"name":"Sidney H. Kennedy","is_ca":true},{"name":"Sakina J. Rizvi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03552954744009842,"gpt":0.3861620325961044,"spread":0.350632485156006,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004195521,0.001006118,0.001201037,0.001281045,0.000298702,0.0007035878,0.0007592721,0.001347581,0.01219669],"category_scores_gemma":[0.0003779937,0.0002098899,0.0005453944,0.001067699,0.0003031092,0.0009735253,0.0006009134,0.001734244,0.009208265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004905987,"about_ca_system_score_gemma":0.000860979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007762811,"about_ca_topic_score_gemma":0.002421856,"domain_scores_codex":[0.9998313,0.00002895275,0.00002280167,0.00002644732,0.00007451785,0.00001601395],"domain_scores_gemma":[0.9998202,0.0000431464,0.00004261511,0.000006622384,0.00006176029,0.00002564727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007931581,0.0001118635,0.00009942759,0.00803129,0.00006909509,0.000426212,0.00003687528,0.0001116055,0.002990511,0.00252087,0.06890443,0.9166185],"study_design_scores_gemma":[0.00007403309,0.0001615286,0.000596966,0.002025632,0.00009165444,0.001785268,0.00003318694,0.00009512648,0.0004651699,0.001655943,0.993004,0.00001153392],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002201191,0.9910805,0.000452017,0.001230137,0.0008413327,0.00003209393,0.00004813925,0.0000315228,0.006064142],"genre_scores_gemma":[0.001260462,0.9896696,0.001226092,0.001656062,0.0007095119,0.00003715233,0.0001083406,0.000003799942,0.005328967],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01219669,"threshold_uncertainty_score":0.040802,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026959104","doi":"10.1517/14728214.2014.882316","title":"Emerging drugs for cystic fibrosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Disease; Regulator; Genetic enhancement; Bioinformatics; Pathology; Internal medicine; Gene; Genetics; Biology","authors":[{"name":"Reshma Amin","is_ca":true},{"name":"Félix Ratjen","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03955102766984114,"gpt":0.4120936363719128,"spread":0.3725426087020717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004887373,0.0008428764,0.0008820237,0.001891318,0.000336077,0.0008582576,0.0008272203,0.001575403,0.0227117],"category_scores_gemma":[0.0007015507,0.0001964528,0.0007833473,0.001120594,0.0003646351,0.001120096,0.0009441121,0.002837453,0.01285051],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006742699,"about_ca_system_score_gemma":0.001137694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00101822,"about_ca_topic_score_gemma":0.002782807,"domain_scores_codex":[0.9997049,0.00004869496,0.00002578312,0.00004397738,0.0001425819,0.00003414675],"domain_scores_gemma":[0.9997417,0.00007239862,0.00004210323,0.00001260349,0.00008742983,0.00004365582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006242281,0.00006378751,0.00007386387,0.006455114,0.0000511973,0.0001958299,0.00004137031,0.0001396444,0.002056237,0.005699881,0.1261974,0.8589633],"study_design_scores_gemma":[0.0000212004,0.00003872601,0.0001453332,0.001099781,0.00002208074,0.0004165938,0.000009958417,0.00003271642,0.0001822314,0.0009765436,0.9970493,0.000005541282],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000248885,0.9824834,0.0005056037,0.002574329,0.002264321,0.00005230644,0.000196217,0.00007444601,0.01160049],"genre_scores_gemma":[0.001853355,0.9805855,0.0008760327,0.002714809,0.0009605989,0.00004878065,0.0003709301,0.00001074898,0.01257933],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0227117,"threshold_uncertainty_score":0.07597816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035774269","doi":"10.1517/14728214.8.2.297","title":"Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Telithromycin; Ketolide; Streptococcus pneumoniae; Microbiology; Macrolide Antibiotics; Efflux; Erythromycin; Medicine; Antibiotics; Biology","authors":[{"name":"George G. Zhanel","is_ca":true},{"name":"Tamiko Hisanaga","is_ca":true},{"name":"Kim Nichol","is_ca":true},{"name":"Aleksandra Wierzbowski","is_ca":true},{"name":"Daryl J. Hoban","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.116053272972563,"gpt":0.4387001288850574,"spread":0.3226468559124944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004156382,0.0008326648,0.001303617,0.001536111,0.0002609518,0.0006857034,0.0006501411,0.001207474,0.004326717],"category_scores_gemma":[0.0003307422,0.0001916673,0.0003849735,0.001631449,0.0002934154,0.001193804,0.0003832406,0.001097392,0.003278413],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004061053,"about_ca_system_score_gemma":0.0008114277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008370612,"about_ca_topic_score_gemma":0.002480098,"domain_scores_codex":[0.9998319,0.00003129237,0.00002222139,0.0000317042,0.00006680156,0.00001610168],"domain_scores_gemma":[0.9998361,0.00004503202,0.00003420254,0.000006171296,0.00005223646,0.00002631343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001263107,0.00009390376,0.0001492046,0.007743575,0.00006186461,0.0003541783,0.0000369994,0.0001753363,0.002823947,0.0008562165,0.0214358,0.9661427],"study_design_scores_gemma":[0.0001115273,0.0003667416,0.001557587,0.001986115,0.0001522955,0.003402035,0.00006951782,0.0001395597,0.0009546048,0.0008849173,0.9903571,0.00001803543],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000292748,0.9977487,0.0001970525,0.0003547,0.0001821415,0.000009222364,0.00001639389,0.00001337947,0.001185622],"genre_scores_gemma":[0.001182672,0.9959616,0.0004780163,0.0004535414,0.0002338942,0.00001425973,0.00005578558,0.000002161363,0.001618096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004326717,"threshold_uncertainty_score":0.01447433,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2091075249","doi":"10.1517/14728214.12.3.367","title":"Pharmacologic therapeutics for cardiac reperfusion injury","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Cardiac Ischemia and Reperfusion","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; University of Lethbridge","keywords":"Medicine; Mitochondrial permeability transition pore; Cardioprotection; Reperfusion injury; Pharmacology; Bradykinin; Potassium channel; Myocardial infarction; Receptor; Ischemia; Internal medicine; Programmed cell death; Biochemistry; Chemistry; Apoptosis","authors":[{"name":"Eric R. Gross","is_ca":false},{"name":"Garrett J. Gross","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08498793500887913,"gpt":0.4486911202970438,"spread":0.3637031852881647,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005690166,0.0009995579,0.001496093,0.002052221,0.0003616323,0.0008041231,0.0008928176,0.001320224,0.007569392],"category_scores_gemma":[0.0004224684,0.0002226461,0.0005632087,0.001454082,0.0004531039,0.001125492,0.0005260349,0.002182966,0.005643217],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005472456,"about_ca_system_score_gemma":0.0007314194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005448672,"about_ca_topic_score_gemma":0.001469432,"domain_scores_codex":[0.9997765,0.00003728513,0.00002689322,0.00002945912,0.0001085401,0.00002123403],"domain_scores_gemma":[0.9998324,0.00005819602,0.00003164983,0.000009410966,0.00004932762,0.00001887423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009765532,0.0002069237,0.00009463516,0.006744151,0.00007205556,0.000460375,0.00005815321,0.000192266,0.004624921,0.003987161,0.03471057,0.948751],"study_design_scores_gemma":[0.00008151885,0.0002064872,0.0005687566,0.001363325,0.00007445373,0.002122377,0.00003431579,0.00009218199,0.0009005205,0.001642504,0.9928999,0.00001372524],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003458181,0.9932331,0.0003546086,0.0006498347,0.0005255968,0.00002675114,0.00002663341,0.00002287167,0.004814612],"genre_scores_gemma":[0.001276332,0.9942116,0.0006736769,0.0005976168,0.0003777529,0.00002715401,0.0000558313,0.000003347422,0.002776647],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007569392,"threshold_uncertainty_score":0.0253222,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999827505","doi":"10.1517/14728214.11.2.275","title":"Emerging drugs for the treatment of chronic obstructive pulmonary disease","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; COPD; Roflumilast; Pulmonary disease; Intensive care medicine; Pharmacology; Immunology; Internal medicine","authors":[{"name":"Samir Malhotra","is_ca":true},{"name":"S. F. Paul Man","is_ca":true},{"name":"Don D. Sin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03966172483524021,"gpt":0.3782209013057312,"spread":0.338559176470491,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009863798,0.001077649,0.001475618,0.002126448,0.0004028426,0.0008828091,0.001018598,0.002032179,0.01016696],"category_scores_gemma":[0.0007458989,0.0002537102,0.0007227355,0.001713041,0.0005232049,0.001627814,0.0007504348,0.002849746,0.008499959],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006855848,"about_ca_system_score_gemma":0.001305815,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001022794,"about_ca_topic_score_gemma":0.002902948,"domain_scores_codex":[0.9995778,0.00007757061,0.00004159054,0.00004775893,0.0002171076,0.00003818376],"domain_scores_gemma":[0.9995913,0.0001097856,0.00006725339,0.0000178465,0.0001511383,0.00006277416],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001124641,0.0001597361,0.0001212323,0.00662662,0.00008681663,0.0003101331,0.00005757519,0.0001853855,0.002709007,0.003279849,0.06366787,0.9226834],"study_design_scores_gemma":[0.00007964553,0.0001705599,0.0004352399,0.001431778,0.00006799066,0.001009546,0.00003345257,0.00007212832,0.000341454,0.001251403,0.9950957,0.00001112315],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001595487,0.9944584,0.0002756502,0.001189713,0.0009346611,0.0000234821,0.00002427764,0.00001675992,0.002917503],"genre_scores_gemma":[0.0007152495,0.9940116,0.0007306034,0.0009857616,0.0007548476,0.00002250582,0.00005470575,0.000002610149,0.002722145],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01016696,"threshold_uncertainty_score":0.03401184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3023787781","doi":"10.1080/14728214.2020.1763954","title":"Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update","year":2020,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Dyskinesia; Pharmacology; Intensive care medicine; Internal medicine; Disease; Parkinson's disease","authors":[{"name":"Sohaila Alshimemeri","is_ca":true},{"name":"Susan H. Fox","is_ca":true},{"name":"Naomi P. Visanji","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0638396933316561,"gpt":0.3895764957156752,"spread":0.325736802384019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005004894,0.0007912242,0.001240782,0.001899574,0.0002035162,0.0009848188,0.0007750638,0.001231336,0.008721462],"category_scores_gemma":[0.0008167124,0.0002043823,0.0006911532,0.001739079,0.0003022077,0.00124658,0.0005486437,0.001950039,0.003785114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005350844,"about_ca_system_score_gemma":0.001006723,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001145793,"about_ca_topic_score_gemma":0.00256021,"domain_scores_codex":[0.9997937,0.00003960734,0.00003647954,0.00003293383,0.00007738289,0.00001995388],"domain_scores_gemma":[0.9995871,0.0001871882,0.00006731992,0.000007976309,0.0001204406,0.00002991063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007836342,0.00005176291,0.00008235262,0.02466605,0.00009492035,0.0001662423,0.00004648013,0.0001721133,0.0008812636,0.001974786,0.05014461,0.9216411],"study_design_scores_gemma":[0.00002927249,0.00008763019,0.0004022947,0.00742269,0.0001832153,0.0009377103,0.00003812478,0.0000740679,0.0001544419,0.001005264,0.9896526,0.00001273837],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007393436,0.9978349,0.00008507554,0.0005328211,0.000345414,0.000007189406,0.00003800545,0.000009871923,0.00107294],"genre_scores_gemma":[0.0004069006,0.9982034,0.0001557895,0.0004149319,0.0002316737,0.000007415749,0.00004962943,0.000001613664,0.0005285616],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008721462,"threshold_uncertainty_score":0.02917624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085013428","doi":"10.1517/14728214.13.2.363","title":"Emerging antidyslipidemic drugs","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Ezetimibe; Tolerability; Adverse effect; Intensive care medicine; Coronary heart disease; Niacin; Pharmacology; Statin; Internal medicine","authors":[{"name":"Rebecca L. Pollex","is_ca":true},{"name":"Tisha Joy","is_ca":true},{"name":"Robert A. Hegele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04300957262493703,"gpt":0.3725274129698519,"spread":0.3295178403449149,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006655783,0.0008506565,0.001374918,0.002008051,0.0002069289,0.0007304535,0.0008217468,0.001013045,0.004258758],"category_scores_gemma":[0.0005776897,0.0002098891,0.0004218585,0.001758636,0.0003063164,0.001072309,0.00043348,0.001152805,0.002478613],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005541381,"about_ca_system_score_gemma":0.001085613,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009040193,"about_ca_topic_score_gemma":0.002043272,"domain_scores_codex":[0.9997286,0.00004479239,0.00003498717,0.00004520859,0.0001216892,0.00002462091],"domain_scores_gemma":[0.9997,0.0001040002,0.00005429978,0.000008552186,0.0001032036,0.00002996552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009040349,0.00007885147,0.0002606933,0.01007885,0.00009034953,0.0003892391,0.00003601837,0.0002536202,0.00198264,0.002103059,0.02182223,0.962814],"study_design_scores_gemma":[0.00007952262,0.0002012488,0.001556352,0.004355415,0.0002091956,0.002920196,0.00007298916,0.0002368598,0.001023158,0.001803669,0.9875238,0.00001750168],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002506536,0.9972112,0.0001862421,0.00037115,0.0002084388,0.000006939664,0.00001583581,0.0000102028,0.00173948],"genre_scores_gemma":[0.001078459,0.9967693,0.0004150174,0.0003753693,0.0002348083,0.000008863778,0.00003855585,0.000001257055,0.001078341],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004258758,"threshold_uncertainty_score":0.01424694,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016233068","doi":"10.1517/14728214.2012.678833","title":"Emerging targets for the treatment of scleroderma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Scleroderma (fungus); Disease; Personalized medicine; Immunology; Bioinformatics; Pathology","authors":[{"name":"Andrew Leask","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1023143997969305,"gpt":0.39166777573168,"spread":0.2893533759347495,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004944943,0.0007714116,0.001223861,0.001680847,0.0002180875,0.0006676313,0.0006732682,0.001056222,0.005870257],"category_scores_gemma":[0.0005035835,0.0001726558,0.0005804265,0.001188493,0.0003424682,0.0008614964,0.0005547101,0.002302196,0.00347976],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004755063,"about_ca_system_score_gemma":0.0006728272,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006759884,"about_ca_topic_score_gemma":0.001673245,"domain_scores_codex":[0.9997626,0.00005129676,0.00002373788,0.00003321983,0.0001035281,0.00002563797],"domain_scores_gemma":[0.9997723,0.00008046183,0.00004292624,0.000007481775,0.0000729259,0.00002391412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009549655,0.00009470876,0.00009741767,0.01051308,0.00009401207,0.0002299213,0.00003832723,0.000328454,0.002733352,0.00352511,0.04161624,0.9406339],"study_design_scores_gemma":[0.00006890765,0.0001400648,0.000686431,0.003878829,0.00009811963,0.001193906,0.00004105186,0.0001267191,0.0006437817,0.00203117,0.9910749,0.00001612085],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001437953,0.9971431,0.0001789554,0.0005726435,0.0003717158,0.00001045762,0.00002888614,0.00001208699,0.001538372],"genre_scores_gemma":[0.001051017,0.9966468,0.0003309317,0.0005425753,0.0002819057,0.00001408486,0.00006790948,0.000002205008,0.001062524],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005870257,"threshold_uncertainty_score":0.01963794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2040792648","doi":"10.1517/14728214.13.1.81","title":"Emerging drugs for malignant glioma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Temozolomide; Radiation therapy; Oncology; Glioblastoma; Chemotherapy; Targeted therapy; Internal medicine; Cancer; Cancer research","authors":[{"name":"Warren Mason","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05204084896289074,"gpt":0.3800900213728202,"spread":0.3280491724099295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005108553,0.001020518,0.001328759,0.002500846,0.0003073844,0.0008984177,0.0007304181,0.00135031,0.007071213],"category_scores_gemma":[0.0004675698,0.0002277163,0.0007315323,0.001725911,0.0004222899,0.001238103,0.0006578442,0.001888371,0.005267601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007839758,"about_ca_system_score_gemma":0.001030786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001005333,"about_ca_topic_score_gemma":0.002371306,"domain_scores_codex":[0.9997376,0.0000463192,0.00003073365,0.00003990551,0.0001208057,0.00002458486],"domain_scores_gemma":[0.9998023,0.00006106319,0.00004267571,0.000008870888,0.00006393805,0.00002128547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006709728,0.0000851802,0.0001269128,0.01107751,0.00009063191,0.00055747,0.00006619204,0.000234883,0.003434876,0.004059072,0.04737982,0.9328204],"study_design_scores_gemma":[0.000041111,0.00008784552,0.0003669836,0.002192307,0.00007114618,0.002141178,0.00003044698,0.00008505069,0.000658876,0.001614498,0.9926996,0.0000111113],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002092693,0.9950211,0.0002796351,0.00070601,0.0004144406,0.00001948843,0.00003084463,0.00001745596,0.003301785],"genre_scores_gemma":[0.001048174,0.9952843,0.0005284692,0.0006168842,0.0002886775,0.00001798455,0.00006971825,0.000002624195,0.002143209],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007071213,"threshold_uncertainty_score":0.02365559,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2140016150","doi":"10.1517/14728214.2015.1050376","title":"Emerging drugs for antipsychotic-induced tardive dyskinesia: investigational drugs in Phase II and Phase III clinical trials","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Tardive dyskinesia; Neurochemical; Dopamine; Medicine; Dopamine receptor D2; Pharmacology; Antipsychotic; Monoamine neurotransmitter; Dyskinesia; Neuroscience; Dopamine receptor; Schizophrenia (object-oriented programming); Serotonin; Internal medicine; Receptor; Psychology; Psychiatry; Parkinson's disease","authors":[{"name":"Jonathan Lockwood","is_ca":true},{"name":"Gary Remington","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2655091623101564,"gpt":0.5465815142672025,"spread":0.2810723519570461,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001497648,0.000840251,0.001973182,0.0007976218,0.0001755908,0.001001626,0.001076762,0.001345648,0.008591088],"category_scores_gemma":[0.001432661,0.0001974313,0.001494047,0.0008971141,0.0003233711,0.000750908,0.0004388263,0.001619859,0.001911276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006262936,"about_ca_system_score_gemma":0.001683334,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008552379,"about_ca_topic_score_gemma":0.002821621,"domain_scores_codex":[0.9996903,0.00008951607,0.00005180674,0.00003858768,0.00009453212,0.0000352422],"domain_scores_gemma":[0.999244,0.0002432862,0.0002300516,0.00001831428,0.000190949,0.00007348607],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001652425,0.0003809284,0.0002354493,0.05668103,0.0005950326,0.0002231342,0.00006492261,0.000393998,0.003483877,0.002317903,0.0455579,0.8884134],"study_design_scores_gemma":[0.005358131,0.004146615,0.002892641,0.0625606,0.003138765,0.001563735,0.000150252,0.0006024392,0.002515888,0.003473266,0.9135175,0.0000802182],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009550398,0.9936087,0.0003614654,0.0009826294,0.0004448172,0.0002138471,0.0002605881,0.00002917515,0.003143819],"genre_scores_gemma":[0.005845307,0.9884689,0.001017147,0.001909767,0.0002947021,0.0002901724,0.0003536784,0.00001018136,0.001810032],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008591088,"threshold_uncertainty_score":0.02874005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394581977","doi":"10.1080/14728214.2024.2340723","title":"Treatment of idiopathic pulmonary fibrosis: an update on emerging drugs in phase II & III clinical trials","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Dalhousie University","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Nintedanib; Pirfenidone; Clinical trial; Intensive care medicine; Pulmonary fibrosis; Disease; Lung; Internal medicine; Fibrosis","authors":[{"name":"S. Macisaac","is_ca":true},{"name":"Dujrath Somboonviboon","is_ca":true},{"name":"Ciaran Scallan","is_ca":true},{"name":"Martin Kolb","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07169041454626408,"gpt":0.436137698945395,"spread":0.3644472843991309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00373922,0.0008760472,0.003228888,0.001342849,0.0003513277,0.002392827,0.001552608,0.002262562,0.01000925],"category_scores_gemma":[0.004765248,0.0003293866,0.002753446,0.001723735,0.0005574402,0.00208685,0.0009176601,0.003184964,0.002813135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001098954,"about_ca_system_score_gemma":0.002600007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000876463,"about_ca_topic_score_gemma":0.002902538,"domain_scores_codex":[0.9988573,0.0004035261,0.0002033281,0.00009000835,0.0003205412,0.0001252426],"domain_scores_gemma":[0.9965338,0.001497588,0.0007140637,0.00008905394,0.0009047485,0.0002607055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0016869,0.0003311695,0.0003947548,0.04452884,0.0005855173,0.000176221,0.0000823767,0.0003140881,0.001973012,0.002549184,0.06618769,0.8811904],"study_design_scores_gemma":[0.003154498,0.003086371,0.002324362,0.09027294,0.003229456,0.0009566589,0.0001686346,0.0004773997,0.001261878,0.004277714,0.890721,0.00006916832],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005995044,0.990209,0.0004163857,0.004244358,0.0009015382,0.0001980777,0.0003471973,0.00003982996,0.003044123],"genre_scores_gemma":[0.004086166,0.9846065,0.001444855,0.00665343,0.0008748505,0.0003917091,0.000498159,0.00002495741,0.001419408],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01000925,"threshold_uncertainty_score":0.03348428,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4395667067","doi":"10.1080/14728214.2024.2346590","title":"Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mediprobe Research (Canada); University of Toronto","funders":"","keywords":"Androgen receptor; Medicine; 5 Alpha-Reductase Inhibitor; Androgen; Finasteride; Pharmacology; Receptor; Internal medicine; Endocrinology; Prostate cancer; Hormone; Cancer","authors":[{"name":"Aditya K. Gupta","is_ca":true},{"name":"Mesbah Talukder","is_ca":true},{"name":"Greg Williams","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04625012959276738,"gpt":0.3528037797185237,"spread":0.3065536501257563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004500575,0.0005168306,0.0008566447,0.001405692,0.0001751033,0.0006735682,0.000656334,0.0008545976,0.008101118],"category_scores_gemma":[0.000711979,0.0001387206,0.0008026368,0.0009297122,0.0002294002,0.0007506022,0.0003838644,0.001563631,0.002428609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003893137,"about_ca_system_score_gemma":0.0006720934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009454731,"about_ca_topic_score_gemma":0.002567414,"domain_scores_codex":[0.9997769,0.00004258856,0.0000261869,0.00003605135,0.00009831771,0.00001989182],"domain_scores_gemma":[0.9997067,0.0001199361,0.00006221009,0.000005662183,0.00008687207,0.00001860924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009540216,0.00005569075,0.0001114554,0.02461363,0.0001441163,0.0001536716,0.0000414485,0.0001771915,0.001385551,0.001923696,0.03379878,0.9374994],"study_design_scores_gemma":[0.00007452304,0.0001640762,0.0009086967,0.01186086,0.0003467833,0.001404209,0.00006516898,0.0001257047,0.0004756245,0.001533683,0.9830235,0.00001731562],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001276848,0.9977416,0.0001096296,0.0005103675,0.0002757446,0.000008303682,0.00002760626,0.000008381988,0.001190738],"genre_scores_gemma":[0.001004203,0.9969663,0.0001976657,0.0005343436,0.0002807853,0.000008368617,0.00004752648,0.000001956465,0.0009588237],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008101118,"threshold_uncertainty_score":0.02710092,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2147313898","doi":"10.1517/14728214.9.2.223","title":"Use of cytokines in infection","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Immune system; Immunology; Medicine; Adjuvant; Cytokine; Antimicrobial; Antibiotics; Vaccination; Infectious disease (medical specialty); Proinflammatory cytokine; Disease; Biology; Inflammation; Microbiology; Internal medicine","authors":[{"name":"Naoko Aoki","is_ca":true},{"name":"Zhou Xing","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1613996187446005,"gpt":0.4539644417797895,"spread":0.292564823035189,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005960842,0.0009600336,0.00134074,0.001687389,0.0003303986,0.001034735,0.0006382902,0.001317908,0.00315574],"category_scores_gemma":[0.0004721919,0.0002466154,0.0004539759,0.001299926,0.000623197,0.001203175,0.0006081895,0.001660409,0.00295703],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006251748,"about_ca_system_score_gemma":0.000764974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006026608,"about_ca_topic_score_gemma":0.0008033396,"domain_scores_codex":[0.9996836,0.00006882561,0.00004160827,0.0000560214,0.0001234917,0.00002653565],"domain_scores_gemma":[0.9997823,0.0001017199,0.00003621247,0.00001143229,0.0000488403,0.0000195203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001834585,0.00009453906,0.0002431995,0.01088232,0.0000615499,0.0006050688,0.0001311431,0.0002627668,0.01091953,0.004557524,0.0187043,0.9533546],"study_design_scores_gemma":[0.00004604064,0.0001776208,0.0006679082,0.001791149,0.00006377837,0.002621182,0.0000549108,0.00006522815,0.003509184,0.00157148,0.9894179,0.00001361327],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001952559,0.9978527,0.0001565533,0.0002182308,0.0003044409,0.000005243397,0.000006013225,0.000006297534,0.001255263],"genre_scores_gemma":[0.001621757,0.9959044,0.0003374316,0.0003290666,0.0003762523,0.00001423686,0.00001759086,0.000002007831,0.001397191],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00315574,"threshold_uncertainty_score":0.010557,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985544005","doi":"10.1517/14728214.2013.811487","title":"Inflammation and the heart – prime time for new therapeutic approaches","year":2013,"lang":"en","type":"letter","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Coronary artery disease; Inflammation; Disease; Intensive care medicine; Clinical trial; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine","authors":[{"name":"François Roubille","is_ca":true},{"name":"Jean‐Claude Tardif","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.037059422539979,"gpt":0.2852610698547764,"spread":0.2482016473147974,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001962367,0.0009874357,0.001814579,0.000741413,0.001294369,0.002457265,0.0009912807,0.01596152,0.007822689],"category_scores_gemma":[0.007129268,0.0003655999,0.0009978233,0.000471771,0.002658257,0.004721162,0.001431224,0.02862919,0.007747896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002519796,"about_ca_system_score_gemma":0.001835952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006800236,"about_ca_topic_score_gemma":0.001314802,"domain_scores_codex":[0.9981875,0.0004878726,0.0001850629,0.0002844059,0.0006595246,0.0001955581],"domain_scores_gemma":[0.9964224,0.00198974,0.0002498706,0.0001390999,0.0007734937,0.0004253423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001052328,0.00004797021,0.000169652,0.0006032576,0.00002744261,0.002709765,0.00009793915,0.00009841346,0.0007304525,0.008230818,0.9109627,0.07621639],"study_design_scores_gemma":[0.00008590924,0.0001024249,0.0003673396,0.001116361,0.00002238402,0.004846605,0.000155818,0.0001575226,0.0002008339,0.01399511,0.9789181,0.00003154318],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0003046175,0.0997012,0.0005063586,0.8340776,0.06207357,0.00001692559,0.00005453886,0.00006621608,0.003198935],"genre_scores_gemma":[0.005327058,0.09977016,0.0008192983,0.5523673,0.3346502,0.00004367135,0.00007451978,0.00003461627,0.006913044],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01596152,"threshold_uncertainty_score":0.02616954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2335279309","doi":"10.1517/14728214.2016.1170117","title":"Emerging drugs for graft-versus-host disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Disease; Clinical trial; Graft-versus-host disease; Immunology; Intensive care medicine; Internal medicine","authors":[{"name":"Natasha Kekre","is_ca":true},{"name":"Joseph H. Antin","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05485852904322683,"gpt":0.3932086352117313,"spread":0.3383501061685044,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000500619,0.0007926528,0.001203541,0.001649025,0.0002279324,0.0008102321,0.0007740618,0.001136278,0.008713073],"category_scores_gemma":[0.000743637,0.000158441,0.0007110948,0.001251009,0.0003370532,0.001075134,0.0005734354,0.002110157,0.003684226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006269245,"about_ca_system_score_gemma":0.001029467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007207106,"about_ca_topic_score_gemma":0.001612761,"domain_scores_codex":[0.9997271,0.0000543284,0.0000344813,0.00003949543,0.0001169957,0.00002767492],"domain_scores_gemma":[0.9996604,0.0001327913,0.00006655794,0.00000949778,0.0001042421,0.00002639611],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006527282,0.00004687077,0.00008257783,0.01669431,0.0001166501,0.0001737177,0.00004023125,0.0002605545,0.001225005,0.003394848,0.06130976,0.9165902],"study_design_scores_gemma":[0.00002111545,0.00005183374,0.0002628308,0.004902929,0.0001034834,0.0008068997,0.00002363714,0.00006686516,0.0002208657,0.001371816,0.9921589,0.000008875525],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009282311,0.9966202,0.0001370264,0.0007157886,0.000505626,0.00001006196,0.00003435519,0.00001116801,0.001872913],"genre_scores_gemma":[0.0006750108,0.9969771,0.0002067848,0.0006385893,0.0002928457,0.00001010965,0.00005787872,0.000002070873,0.001139629],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008713073,"threshold_uncertainty_score":0.0291481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067328075","doi":"10.1517/14728210903203790","title":"Antigen-specific therapies in multiple sclerosis","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Effector; Antigen; Immunology; Immune system; Neuroscience; Biology","authors":[{"name":"Paul S. Giacomini","is_ca":true},{"name":"Amit Bar‐Or","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2141295040898592,"gpt":0.4057707716530308,"spread":0.1916412675631716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009282261,0.0007493536,0.00124629,0.001862017,0.0002838736,0.0006332742,0.0007793712,0.001418315,0.003532775],"category_scores_gemma":[0.0006330295,0.0001929873,0.0004046907,0.001689123,0.000570366,0.001148509,0.0005175637,0.001616016,0.002736398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00063864,"about_ca_system_score_gemma":0.001092813,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008255151,"about_ca_topic_score_gemma":0.001504603,"domain_scores_codex":[0.999719,0.0000730519,0.00003713511,0.00003006118,0.0001213003,0.00001945081],"domain_scores_gemma":[0.9997371,0.0001200246,0.00004641194,0.00001040613,0.00006313583,0.00002299585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009180074,0.00011983,0.0001016379,0.01572004,0.00008023782,0.0004179055,0.0000616431,0.0003741161,0.002759901,0.00463492,0.03807428,0.9375638],"study_design_scores_gemma":[0.00005369365,0.0001744398,0.0006026166,0.004604336,0.00008736227,0.002459534,0.00006054583,0.00009643746,0.0006844204,0.003532535,0.9876285,0.00001576056],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007164074,0.9983082,0.000103884,0.0003539172,0.0002532771,0.000006720285,0.000005656679,0.000005923814,0.0008907908],"genre_scores_gemma":[0.0005193636,0.9982981,0.0002178052,0.000246806,0.0002334245,0.000007896814,0.00001035903,7.821297e-7,0.0004655121],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003532775,"threshold_uncertainty_score":0.01181829,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1974479297","doi":"10.1517/14728214.2014.955014","title":"Emerging drugs for levodopa-induced dyskinesia","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Levodopa; Medicine; Dyskinesia; Intensive care medicine; Disease; Parkinson's disease; Internal medicine","authors":[{"name":"Amaal Al Dakheel","is_ca":true},{"name":"Isabelle Beaulieu‐Boire","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05619929424255898,"gpt":0.3902307493660356,"spread":0.3340314551234767,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004591256,0.0009772959,0.001235601,0.002182951,0.00026383,0.0008799512,0.000769877,0.001291846,0.009236891],"category_scores_gemma":[0.00054605,0.0001883356,0.0006917722,0.002053319,0.0003949092,0.001156172,0.0005653296,0.002253695,0.005236695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007405028,"about_ca_system_score_gemma":0.001067114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001079983,"about_ca_topic_score_gemma":0.002517073,"domain_scores_codex":[0.9997857,0.00003745261,0.00003103288,0.00003622852,0.0000887865,0.0000208319],"domain_scores_gemma":[0.9997278,0.00009331292,0.00006280903,0.000007941263,0.00008639166,0.00002172442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007109732,0.00005848406,0.00008556946,0.02107431,0.00009194265,0.0002249556,0.00004528272,0.0001416809,0.001530348,0.003032532,0.05114932,0.9224945],"study_design_scores_gemma":[0.00003106454,0.00007063163,0.0004933604,0.006301038,0.0001336093,0.001308407,0.00003673593,0.00006519624,0.0003518068,0.001379516,0.9898179,0.00001074365],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006920997,0.9974986,0.0001084748,0.0004405204,0.0002875063,0.00001120669,0.00002751638,0.00001084845,0.001546135],"genre_scores_gemma":[0.000704063,0.996877,0.0002494328,0.0005363273,0.0002354712,0.000013141,0.00005572583,0.000002183757,0.001326576],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009236891,"threshold_uncertainty_score":0.03090054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075748215","doi":"10.1517/14728214.2015.985204","title":"Emerging drugs for celiac disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Internal medicine","authors":[{"name":"Hugh James Freeman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04708593854982716,"gpt":0.4214706061184548,"spread":0.3743846675686276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006049922,0.0007425136,0.00121093,0.002135121,0.0002307653,0.0009569388,0.000829228,0.001540588,0.01335203],"category_scores_gemma":[0.0009211645,0.0001957271,0.0008677188,0.00163839,0.0003660045,0.001039545,0.0006546879,0.002216003,0.005444099],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007169446,"about_ca_system_score_gemma":0.001214062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001042219,"about_ca_topic_score_gemma":0.002262075,"domain_scores_codex":[0.9996749,0.00007011128,0.00004344562,0.00004593618,0.0001350106,0.00003050639],"domain_scores_gemma":[0.9995905,0.0001519108,0.00008704167,0.00001295059,0.0001231312,0.00003460631],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007178236,0.00004866594,0.00009061325,0.02794265,0.0001419954,0.0001973239,0.00005091773,0.0001214045,0.001162283,0.003581582,0.07130609,0.8952847],"study_design_scores_gemma":[0.00003901103,0.00005533883,0.0003583678,0.007833761,0.0001325152,0.0008423146,0.00002900663,0.00004651224,0.0001823167,0.001291247,0.9891802,0.000009455935],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000847874,0.995616,0.0001141837,0.001147835,0.0007247844,0.00001500249,0.00004057872,0.00001264678,0.002244257],"genre_scores_gemma":[0.0008340736,0.9957948,0.0002339918,0.001076965,0.0004471857,0.00001429089,0.00007323668,0.000001969506,0.001523537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01335203,"threshold_uncertainty_score":0.04466701,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001823700","doi":"10.1517/14728210903142147","title":"Emerging drugs for prostate cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Angiogenesis; Androgen receptor; Pharmacology; Matrix metalloproteinase inhibitor; Tyrosine kinase; Cancer; Cancer research; Matrix metalloproteinase; Internal medicine; Receptor","authors":[{"name":"Kashif Siddiqui","is_ca":true},{"name":"Laurence Klotz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0657725239338676,"gpt":0.4459334391320053,"spread":0.3801609151981378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805177,0.00126699,0.001307323,0.002243484,0.000375068,0.000921668,0.001021902,0.001467543,0.0142307],"category_scores_gemma":[0.0004883582,0.0002659167,0.0006988188,0.001669608,0.0005078546,0.001362493,0.0009952527,0.003242109,0.0103798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000738947,"about_ca_system_score_gemma":0.0009426577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001148751,"about_ca_topic_score_gemma":0.003175992,"domain_scores_codex":[0.9997216,0.00005197756,0.00002425913,0.00004369751,0.0001303726,0.00002800791],"domain_scores_gemma":[0.9997851,0.0000691868,0.00003819579,0.0000122548,0.00006451988,0.00003081351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007305871,0.0001256021,0.00007733075,0.006916281,0.00006553675,0.0003115464,0.00004892465,0.0002496184,0.002982912,0.006429219,0.0838218,0.8988982],"study_design_scores_gemma":[0.00002922912,0.00006092808,0.0001702603,0.0009187113,0.00002588248,0.0007092798,0.00001312808,0.00004616956,0.0002355341,0.001172315,0.9966115,0.000006999846],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001486381,0.991508,0.0003605696,0.0007210549,0.0009606903,0.00002885903,0.00005155834,0.0000294967,0.006191129],"genre_scores_gemma":[0.00112596,0.9880642,0.0009413815,0.001275603,0.0006280077,0.00003989898,0.0001445921,0.000006561917,0.007773704],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0142307,"threshold_uncertainty_score":0.04760641,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2548436673","doi":"10.1080/14728214.2016.1257607","title":"Emerging drugs and therapeutics for systemic sclerosis","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Context (archaeology); Scleroderma (fungus); Interstitial lung disease; Multiple sclerosis; Systemic disease; Bioinformatics; Immunology; Pathology; Lung; Internal medicine","authors":[{"name":"Jason J. Lee","is_ca":true},{"name":"Janet Pope","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07706061920886499,"gpt":0.3731720748649865,"spread":0.2961114556561216,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006911313,0.0008387288,0.001135489,0.002102879,0.0002745764,0.00099152,0.000729543,0.001553989,0.007942254],"category_scores_gemma":[0.0008893539,0.0001992557,0.0007352533,0.001393336,0.000504068,0.001361681,0.0007452662,0.003070008,0.003864054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007388121,"about_ca_system_score_gemma":0.001217819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007870147,"about_ca_topic_score_gemma":0.001784568,"domain_scores_codex":[0.9996119,0.00007829403,0.00004654375,0.00005341537,0.0001738885,0.00003596393],"domain_scores_gemma":[0.9995204,0.0002007555,0.00007832137,0.00001473671,0.0001443411,0.00004156325],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006568873,0.0000628992,0.0001026012,0.01635273,0.0001025043,0.0002385692,0.00006421223,0.0003041509,0.001986018,0.006373162,0.06398138,0.9103661],"study_design_scores_gemma":[0.00002116194,0.00006494045,0.0002955853,0.00425939,0.00007528528,0.0008961586,0.00003043683,0.00009927028,0.0003183952,0.002329644,0.9915979,0.00001185897],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009374337,0.9962206,0.0001853329,0.001055013,0.0006332215,0.000009252333,0.00002612324,0.00001256674,0.00176422],"genre_scores_gemma":[0.0008384149,0.9960524,0.0003046548,0.0008552991,0.0005159368,0.00001139511,0.0000531278,0.00000228678,0.001366574],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007942254,"threshold_uncertainty_score":0.02656949,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399261264","doi":"10.1080/14728214.2024.2363215","title":"Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Weston Brain Institute","keywords":"Apathy; Medicine; Psychosis; Psychiatry; Disease; Adverse effect; Dementia; Cognitive decline; Alzheimer's disease; Intensive care medicine; Cognition; Pharmacology; Internal medicine","authors":[{"name":"Hui Jue Wang","is_ca":true},{"name":"Arun Chinna‐Meyyappan","is_ca":true},{"name":"Oriel J. Feldman","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1089756636526861,"gpt":0.4756428104654163,"spread":0.3666671468127302,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609361,0.0007191207,0.001274341,0.0015226,0.0001872105,0.0007636725,0.0007509524,0.001208096,0.006153849],"category_scores_gemma":[0.0008741044,0.0001595002,0.0008757789,0.001090119,0.0002875561,0.0007891603,0.0004807381,0.001594804,0.001957038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005073567,"about_ca_system_score_gemma":0.0009757036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051831,"about_ca_topic_score_gemma":0.002929338,"domain_scores_codex":[0.9997193,0.00006084526,0.00004571333,0.00003864654,0.0001126328,0.00002277276],"domain_scores_gemma":[0.9996614,0.0001569708,0.00007125015,0.00000668663,0.00008641147,0.00001729741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008742114,0.00005678352,0.00007402931,0.05138267,0.0002130612,0.0001339712,0.0000622712,0.0002078938,0.001062501,0.002008379,0.02977544,0.9149356],"study_design_scores_gemma":[0.000108242,0.0001898293,0.0009153305,0.03291969,0.0006553252,0.001204437,0.000094812,0.0001522635,0.000396217,0.002502834,0.9608381,0.00002279558],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007963107,0.9985158,0.00007820237,0.000347011,0.0002012424,0.000009960879,0.00002279207,0.000006063686,0.0007392886],"genre_scores_gemma":[0.000628083,0.9982009,0.0001708988,0.0003669579,0.000149949,0.00001178543,0.00003033678,0.00000109512,0.0004400177],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006153849,"threshold_uncertainty_score":0.02058667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122042922","doi":"10.1517/14728214.2012.681301","title":"Emerging drugs for major depressive disorder: an update","year":2012,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Treatment of Major Depression","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Major depressive disorder; Psychiatry; Pharmacology; Mood","authors":[{"name":"Sakina J. Rizvi","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01387667962968207,"gpt":0.3389484737818395,"spread":0.3250717941521574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003815733,0.002231207,0.002988873,0.002235879,0.0008577253,0.002443309,0.002026943,0.006651577,0.00437456],"category_scores_gemma":[0.006379222,0.0005832518,0.001676829,0.001277019,0.000961828,0.002968923,0.0008331402,0.009107791,0.002941695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001373023,"about_ca_system_score_gemma":0.001845637,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001083539,"about_ca_topic_score_gemma":0.004663445,"domain_scores_codex":[0.9984302,0.0003196564,0.0003242734,0.0001387608,0.0006680971,0.0001190998],"domain_scores_gemma":[0.9944751,0.002478501,0.0005608266,0.0001033447,0.001889632,0.0004925908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001538621,0.00004194563,0.00006778025,0.002158251,0.0001110881,0.0003432135,0.00002148698,0.0000544249,0.0002241768,0.0005060852,0.9165475,0.07977007],"study_design_scores_gemma":[0.000202298,0.0001168394,0.0003177669,0.001667521,0.0002819846,0.0008081907,0.00003183137,0.0001327069,0.0001202972,0.0005270462,0.9957749,0.0000185923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0002127451,0.3616448,0.0005129258,0.04632386,0.5876976,0.00004551555,0.0001157661,0.00008029793,0.003366434],"genre_scores_gemma":[0.001516591,0.2957472,0.0008743595,0.04806621,0.6439891,0.00004882269,0.0001198212,0.00003288076,0.009605031],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.006651577,"threshold_uncertainty_score":0.02017981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4365811101","doi":"10.1080/14728214.2023.2203912","title":"Emerging drugs in the treatment of chronic cough","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Chronic cough; Intensive care medicine; Narrative review; Disease; Expert opinion; Bioinformatics; Internal medicine; Asthma","authors":[{"name":"Danica Brister","is_ca":true},{"name":"Mustafaa Wahab","is_ca":true},{"name":"Moaaz Rashad","is_ca":true},{"name":"Nermin Diab","is_ca":true},{"name":"Martin Kolb","is_ca":true},{"name":"Imran Satia","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1032706225972402,"gpt":0.4426686503978257,"spread":0.3393980278005855,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045384,0.0005018861,0.001039325,0.0015406,0.0002058761,0.000791891,0.0005415006,0.0008773718,0.00733399],"category_scores_gemma":[0.0007519144,0.0001440202,0.0008880448,0.001043191,0.0002553385,0.0007294341,0.000488802,0.001514745,0.001957061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004735506,"about_ca_system_score_gemma":0.0008998172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009023727,"about_ca_topic_score_gemma":0.002094961,"domain_scores_codex":[0.9997485,0.00005752065,0.000037562,0.00003838036,0.00008973693,0.00002826365],"domain_scores_gemma":[0.9996719,0.0001657589,0.00005988917,0.000007270426,0.00007676586,0.00001838614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001262349,0.00006692736,0.0001230526,0.0454085,0.0001766408,0.0001719858,0.00006435452,0.0002424054,0.001476361,0.002802531,0.02374872,0.9255924],"study_design_scores_gemma":[0.00006455449,0.0001776467,0.0008474008,0.01808,0.0003477497,0.00117448,0.00006731234,0.0001334682,0.0005462678,0.001649816,0.9768927,0.00001862104],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001240395,0.9982942,0.00006923908,0.0002764223,0.0002202133,0.000009185263,0.0000262451,0.000006170306,0.0009742817],"genre_scores_gemma":[0.001158044,0.9976267,0.0001364718,0.0003013543,0.0001443157,0.00001065821,0.000038927,0.00000133843,0.0005821896],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00733399,"threshold_uncertainty_score":0.02453464,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4379598629","doi":"10.1080/14728214.2023.2218643","title":"Emerging peptide therapeutics for the treatment of ovarian cancer","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ovarian cancer; Cancer; Peptide; Oncology; Internal medicine; Cancer research; Biology; Biochemistry","authors":[{"name":"Ana Veneziani","is_ca":true},{"name":"Eduardo González-Ochoa","is_ca":true},{"name":"Amit M. Oza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09083098333692492,"gpt":0.4018117388492976,"spread":0.3109807555123727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004211501,0.0006518712,0.001019699,0.001624063,0.0001833563,0.0007398183,0.0005003354,0.000905563,0.004194085],"category_scores_gemma":[0.0004778967,0.0001450143,0.0005147731,0.001348858,0.0003106419,0.0008327211,0.00050065,0.00163759,0.001794089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000468993,"about_ca_system_score_gemma":0.0006629791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006373073,"about_ca_topic_score_gemma":0.001107173,"domain_scores_codex":[0.9998337,0.00003124271,0.00001864456,0.00002482392,0.00007199457,0.0000196148],"domain_scores_gemma":[0.9998511,0.00006007828,0.0000321167,0.000003325121,0.00003866978,0.00001473612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001018719,0.00006474356,0.0001047407,0.02418789,0.0001041053,0.0002412776,0.00004944887,0.0002999116,0.003762884,0.002416871,0.021191,0.9474752],"study_design_scores_gemma":[0.00005680595,0.0002014793,0.0008857244,0.008080422,0.0001737835,0.001814889,0.0000628011,0.0001194673,0.001137705,0.002201726,0.985247,0.00001811786],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001156188,0.9986643,0.00008647037,0.000205193,0.0001828385,0.000006576797,0.00001374589,0.000004192852,0.0007210955],"genre_scores_gemma":[0.0007998889,0.9981674,0.0001368824,0.0002486501,0.00013662,0.000008750164,0.00002700711,0.000001021862,0.0004737361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004194085,"threshold_uncertainty_score":0.01403058,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404445324","doi":"10.1080/14728214.2024.2426649","title":"ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; McGill University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Glioma; Cancer research","authors":[{"name":"Jordan R. Hansford","is_ca":false},{"name":"Neevika Manoharan","is_ca":false},{"name":"Gauthier Bouche","is_ca":false},{"name":"Vijay Ramaswamy","is_ca":true},{"name":"Nada Jabado","is_ca":true},{"name":"Éric Bouffet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06663130938689137,"gpt":0.4072833999992634,"spread":0.340652090612372,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002504392,0.001225908,0.002532508,0.001426639,0.000644511,0.002236879,0.002099382,0.003844634,0.009067415],"category_scores_gemma":[0.007745166,0.0003284393,0.001414731,0.001162734,0.0007091549,0.002214446,0.0006753409,0.005454821,0.006126084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001232374,"about_ca_system_score_gemma":0.001948032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463264,"about_ca_topic_score_gemma":0.003801154,"domain_scores_codex":[0.9990945,0.0002517183,0.0001558535,0.00009933217,0.0003310242,0.00006757],"domain_scores_gemma":[0.996711,0.001592406,0.0003171585,0.00004384911,0.001088831,0.0002467052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002076207,0.00001430385,0.00002693087,0.006271405,0.0001131878,0.0001030334,0.00001933558,0.00003851457,0.0001255651,0.0005452535,0.904766,0.08776876],"study_design_scores_gemma":[0.0002366634,0.0001037218,0.0003027448,0.006566256,0.0004342342,0.0004873829,0.00004330525,0.00009297876,0.0001389187,0.001178394,0.9903922,0.00002328602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.0001625711,0.60171,0.0002704114,0.04521829,0.3475972,0.00006747988,0.0002693457,0.00009690635,0.004607863],"genre_scores_gemma":[0.001773891,0.5955012,0.0004203145,0.06448861,0.3249939,0.0000958087,0.0003289361,0.00006020761,0.01233706],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.009067415,"threshold_uncertainty_score":0.03033352,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390744213","doi":"10.1080/14728214.2024.2303116","title":"Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Janus kinase; Clinical trial; Disease; Vedolizumab; Narrative review; Inflammatory bowel disease; Intensive care medicine; Bioinformatics; Pharmacology; Immunology; Internal medicine; Cytokine","authors":[{"name":"Panu Wetwittayakhlang","is_ca":true},{"name":"Talat Bessissow","is_ca":true},{"name":"Péter L. Lakatos","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05332353335246805,"gpt":0.4074374476504162,"spread":0.3541139142979482,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001754088,0.0009215746,0.002333265,0.001765101,0.0002286677,0.001112913,0.001262548,0.001230264,0.006151449],"category_scores_gemma":[0.002483069,0.0002740462,0.001857421,0.001891741,0.000345558,0.001084147,0.0005670589,0.001706403,0.001568979],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007791916,"about_ca_system_score_gemma":0.001852393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008317454,"about_ca_topic_score_gemma":0.002095958,"domain_scores_codex":[0.9995105,0.0001408204,0.00009815287,0.00006649278,0.0001403406,0.00004363257],"domain_scores_gemma":[0.9987041,0.000743625,0.0001956919,0.00002654418,0.000262378,0.00006760952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005453867,0.00008554021,0.0001224555,0.06906281,0.0004767468,0.0001158303,0.00004515793,0.000307605,0.001120609,0.001530237,0.03115308,0.8954346],"study_design_scores_gemma":[0.0005643146,0.0008623882,0.001351683,0.06673051,0.002733663,0.00108628,0.00007485517,0.0002266247,0.0008429788,0.001779565,0.9237019,0.00004530904],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001094781,0.9985664,0.0001019432,0.0003274994,0.0001990951,0.00002920585,0.0000635305,0.000006774067,0.0005961284],"genre_scores_gemma":[0.0007503555,0.9978881,0.0002561824,0.0005399853,0.0001449588,0.00003834955,0.00007766032,0.000003135581,0.0003012677],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006151449,"threshold_uncertainty_score":0.02057862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144409780","doi":"10.1517/14728214.6.2.281","title":"Pharmacological treatment for prevention of restenosis","year":2001,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"Pfizer","keywords":"Restenosis; Medicine; Intimal hyperplasia; Neointimal hyperplasia; Cardiology; Angioplasty; Coronary artery disease; Conventional PCI; Internal medicine; Percutaneous coronary intervention; Neointima; Interventional cardiology; Stent; Myocardial infarction; Smooth muscle","authors":[{"name":"Jacek Linde","is_ca":true},{"name":"Bradley H. Strauss","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08141778822303335,"gpt":0.4207583856965823,"spread":0.3393405974735489,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000422668,0.0005432672,0.0009187453,0.000855363,0.0002112161,0.0007337344,0.0006512288,0.001312181,0.007263456],"category_scores_gemma":[0.0005688005,0.0001149487,0.0005773008,0.0003681252,0.0003150597,0.0006196491,0.00043858,0.00214441,0.003745748],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004048416,"about_ca_system_score_gemma":0.0004575747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004084294,"about_ca_topic_score_gemma":0.0009311536,"domain_scores_codex":[0.999671,0.00008190462,0.00003855295,0.00004922619,0.0001255227,0.00003381573],"domain_scores_gemma":[0.9997631,0.00007746676,0.00005010792,0.000008575896,0.00007991149,0.00002086714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003189009,0.0003828888,0.0002983878,0.01094271,0.0002101175,0.0004221499,0.00005710696,0.0001958337,0.01017422,0.005550093,0.0631907,0.9082569],"study_design_scores_gemma":[0.0002529598,0.0007309308,0.002028935,0.003364744,0.0002630117,0.00174254,0.00005595662,0.0002580643,0.002607789,0.003164682,0.9854985,0.00003191883],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000836146,0.9874808,0.001074454,0.00398554,0.001232561,0.00004509664,0.0001062494,0.00005521543,0.005183914],"genre_scores_gemma":[0.007401081,0.9820057,0.001283669,0.003003998,0.001955418,0.00007112684,0.0002144447,0.00001348074,0.004051094],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007263456,"threshold_uncertainty_score":0.02429867,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391402131","doi":"10.1080/14728214.2024.2312817","title":"How will tovorafenib change our treatment of pediatric low-grade glioma?","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Emerging Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Oncology; Intensive care medicine; Cancer research","authors":[{"name":"İnci Yaman Bajin","is_ca":true},{"name":"Éric Bouffet","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03407019048588678,"gpt":0.3377245327762583,"spread":0.3036543422903715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003333086,0.001171749,0.001978765,0.001089391,0.0008642998,0.002355192,0.002320743,0.00657677,0.0076019],"category_scores_gemma":[0.0106322,0.0003947579,0.001747627,0.0005137883,0.0008369448,0.002952781,0.0006052866,0.01129192,0.006854131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001705826,"about_ca_system_score_gemma":0.001901478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001372816,"about_ca_topic_score_gemma":0.004100837,"domain_scores_codex":[0.9987808,0.0002618227,0.0001902872,0.0001251646,0.0005110424,0.0001309293],"domain_scores_gemma":[0.9947707,0.002150874,0.0003279756,0.00009665491,0.002030781,0.0006229317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007996466,0.00001430497,0.00002938113,0.0006724093,0.0000420111,0.00009638397,0.00001021731,0.00004006468,0.00009922735,0.0004449865,0.9666549,0.03181602],"study_design_scores_gemma":[0.0001434143,0.00007322351,0.000237296,0.0008278397,0.0001342857,0.0003241439,0.00002380702,0.0001191729,0.000143497,0.001334408,0.996619,0.00002006003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0002123962,0.087463,0.0003591408,0.1103382,0.7960927,0.00005988718,0.0002174157,0.0001358873,0.005121335],"genre_scores_gemma":[0.001754872,0.09624873,0.0005012918,0.129235,0.7555646,0.00007475357,0.0002450374,0.00008897157,0.01628662],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.0076019,"threshold_uncertainty_score":0.02543086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4399385857","doi":"10.1080/14728214.2024.2363213","title":"Emerging drugs for the treatment of benign prostatic hyperplasia: a 2023 update","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Lower urinary tract symptoms; Hyperplasia; cGMP-specific phosphodiesterase type 5; Benign prostatic hyperplasia (BPH); Intensive care medicine; Primary care; Primary treatment; Modalities; 5 Alpha-Reductase Inhibitor; Urology; Prostate; Internal medicine; Gynecology; Erectile dysfunction; Finasteride; Cancer; Family medicine","authors":[{"name":"Joshua Winograd","is_ca":false},{"name":"Nikit Venishetty","is_ca":false},{"name":"Alia Codelia‐Anjum","is_ca":false},{"name":"Naeem Bhojani","is_ca":true},{"name":"Dean Elterman","is_ca":true},{"name":"Kevin C. Zorn","is_ca":true},{"name":"Alexis E. Te","is_ca":false},{"name":"Bilal Chughtai","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07313921420710602,"gpt":0.4351080879869832,"spread":0.3619688737798772,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001238459,0.000904754,0.001846603,0.004069724,0.00031905,0.001368541,0.0009786903,0.001642472,0.009103389],"category_scores_gemma":[0.002252071,0.0003116142,0.00144938,0.003808101,0.0003943543,0.001643759,0.0007487272,0.001744039,0.002333516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001045907,"about_ca_system_score_gemma":0.00285639,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001891193,"about_ca_topic_score_gemma":0.005104042,"domain_scores_codex":[0.9994165,0.0001244065,0.0001287908,0.00006054106,0.0002235219,0.00004634969],"domain_scores_gemma":[0.9984056,0.0008345153,0.0002831607,0.00002672533,0.0003812971,0.0000687114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000129165,0.00005616998,0.0001406184,0.1102988,0.0002173589,0.000187704,0.00008328465,0.0001638288,0.0007884424,0.001761949,0.0445752,0.8415975],"study_design_scores_gemma":[0.00005409576,0.000156811,0.001140763,0.07781265,0.001026972,0.001166983,0.00009981952,0.00009758954,0.0002190653,0.001107291,0.9170952,0.00002278841],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007008605,0.9983037,0.00004556001,0.0004742368,0.0003063935,0.00001138543,0.00003997007,0.000006985594,0.0007416515],"genre_scores_gemma":[0.0003444588,0.9985616,0.0001383655,0.0004264925,0.0001697235,0.00001013052,0.00004789715,0.000001515661,0.0002998447],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009103389,"threshold_uncertainty_score":0.03045386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019398901","doi":"10.1517/14728214.11.2.217","title":"Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Reverse transcriptase; Pharmacology; Nucleoside Reverse Transcriptase Inhibitor; Reverse-transcriptase inhibitor; Dosing; Drug; Regimen; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral load; Internal medicine; Biology; RNA","authors":[{"name":"Claude Fortin","is_ca":true},{"name":"Véronique Joly","is_ca":false},{"name":"Patrick Yéni","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03402692502663547,"gpt":0.3494930753719826,"spread":0.3154661503453471,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007714329,0.001128845,0.001335675,0.001931225,0.0002719593,0.0005810853,0.00105898,0.001447713,0.006365166],"category_scores_gemma":[0.0005948478,0.0002246328,0.0005776816,0.001506018,0.000336344,0.0009714895,0.0004493711,0.001625948,0.006444725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004443355,"about_ca_system_score_gemma":0.001046775,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008443085,"about_ca_topic_score_gemma":0.002466082,"domain_scores_codex":[0.9997016,0.00005048674,0.00002957638,0.00003477525,0.0001537332,0.00002981989],"domain_scores_gemma":[0.9997438,0.00008071362,0.00005598696,0.000008372866,0.00007764129,0.00003349443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007948337,0.0001116075,0.0001189341,0.007772375,0.00006103943,0.0003204469,0.00005429375,0.000129291,0.00269647,0.001236937,0.02935473,0.9580644],"study_design_scores_gemma":[0.00008086841,0.0002084986,0.0008714843,0.002169622,0.00009641719,0.002438862,0.0000407802,0.0000663727,0.0006779267,0.0008040489,0.9925324,0.00001256842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001829012,0.995793,0.0002722695,0.0003740803,0.0003666737,0.00002560055,0.00002085707,0.00001285511,0.002951727],"genre_scores_gemma":[0.0008678919,0.9948804,0.0007510484,0.0005122985,0.0003145614,0.00002460138,0.00006421788,0.000002358535,0.002582652],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006365166,"threshold_uncertainty_score":0.02129364,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394816071","doi":"10.1080/14728214.2024.2339906","title":"Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Head and neck; Incidence (geometry); Monoclonal antibody; Head and neck cancer; Immunotherapy; Antibody; Cancer; Immunology; Surgery","authors":[{"name":"Francis Proulx-Rocray","is_ca":true},{"name":"Denis Soulières","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03019522110742881,"gpt":0.3631607518519307,"spread":0.3329655307445019,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005311465,0.0002660445,0.0004459335,0.0003717639,0.0001219731,0.000552673,0.0003701864,0.0007453422,0.004781599],"category_scores_gemma":[0.0005484442,0.00006286552,0.0003731576,0.0002668483,0.0001767296,0.0006442097,0.0002490593,0.001142718,0.00210006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005442766,"about_ca_system_score_gemma":0.0005062999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005653778,"about_ca_topic_score_gemma":0.002129628,"domain_scores_codex":[0.9998338,0.00003994449,0.0000130144,0.0000213947,0.0000702267,0.00002166459],"domain_scores_gemma":[0.9997851,0.00005929368,0.0000354712,0.000004636535,0.00008966135,0.00002584262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000254983,0.00007690943,0.0004860691,0.005055534,0.0001087661,0.0003840353,0.00003591832,0.0002898092,0.0057965,0.003329372,0.08763798,0.8965441],"study_design_scores_gemma":[0.0001233488,0.0003848902,0.001112366,0.001547087,0.0001183343,0.001331422,0.00003905535,0.0002529183,0.001640105,0.001790151,0.9916496,0.0000107141],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001837906,0.9810647,0.0006182011,0.00706822,0.002267104,0.00003032925,0.00009500264,0.00003262049,0.006985952],"genre_scores_gemma":[0.01777843,0.9636356,0.001166645,0.00660545,0.003270441,0.00003866973,0.0002827065,0.000008224723,0.007213825],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004781599,"threshold_uncertainty_score":0.01599604,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4406242635","doi":"10.1080/14728214.2025.2452514","title":"Seltorexant for major depressive disorder","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Brain and Cognition Discovery Foundation; University Health Network","funders":"","keywords":"Major depressive disorder; Tolerability; Orexin; Medicine; Preclinical research; Cognition; Psychiatry; Neuroscience; Pharmacology; Clinical psychology; Psychology; Internal medicine; Receptor; Adverse effect; Neuropeptide","authors":[{"name":"Kyle Valentino","is_ca":true},{"name":"Kayla M. Teopiz","is_ca":true},{"name":"Sabrina Wong","is_ca":true},{"name":"M Zhang","is_ca":true},{"name":"Gia Han Le","is_ca":true},{"name":"Hayun Choi","is_ca":true},{"name":"Hana Ballum","is_ca":true},{"name":"Christine E. Dri","is_ca":true},{"name":"William W. L. Cheung","is_ca":true},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07306809664989065,"gpt":0.4213677283415115,"spread":0.3482996316916209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005319385,0.000671256,0.001568744,0.001863051,0.0001787999,0.0006131998,0.0006917291,0.000732273,0.01024032],"category_scores_gemma":[0.001026574,0.0001670266,0.001109153,0.001396445,0.0002450875,0.000464588,0.000485491,0.0008395184,0.001819713],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004715491,"about_ca_system_score_gemma":0.0008604365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001152406,"about_ca_topic_score_gemma":0.003114305,"domain_scores_codex":[0.9997328,0.0000702551,0.00007039325,0.00004217311,0.00006668749,0.00001754317],"domain_scores_gemma":[0.9996874,0.0001629575,0.00009302163,0.000004908756,0.00003611733,0.00001557493],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002693792,0.0000341466,0.0001066434,0.1984017,0.0006539467,0.0001717961,0.00004780082,0.0001616661,0.0006434123,0.001066193,0.02263615,0.7758071],"study_design_scores_gemma":[0.0007093626,0.0004445094,0.003387891,0.1720565,0.004617332,0.002402558,0.0001345505,0.0001877848,0.0008282706,0.001995789,0.8132004,0.00003511414],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001179059,0.9987332,0.00004186846,0.0001474682,0.0001002071,0.00001686829,0.00005144593,0.000006193765,0.000784752],"genre_scores_gemma":[0.002129849,0.9964948,0.000145483,0.0004336105,0.0001029687,0.00002820992,0.00008196394,0.000001642594,0.0005815332],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01024032,"threshold_uncertainty_score":0.03425729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025784617","doi":"10.1517/14728214.10.1.67","title":"The drug-based pipeline against restenosis","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Restenosis; Medicine; Drug; Conventional PCI; Sirolimus; Paclitaxel; Percutaneous coronary intervention; Intensive care medicine; Stent; Internal medicine; Cardiology; Pharmacology; Myocardial infarction; Chemotherapy","authors":[{"name":"Pierre‐Frédéric Keller","is_ca":true},{"name":"Réda Ibrahim","is_ca":true},{"name":"Jean‐Claude Tardif","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05339832418767139,"gpt":0.3957091822183103,"spread":0.3423108580306389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000705605,0.0008075124,0.001220705,0.001650097,0.0002995747,0.0008116373,0.0006738182,0.001186213,0.005567102],"category_scores_gemma":[0.0004810253,0.0002010513,0.0003537921,0.001374221,0.0003956938,0.00127765,0.0004298101,0.001481154,0.004961411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005462117,"about_ca_system_score_gemma":0.0009143684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007071172,"about_ca_topic_score_gemma":0.001911771,"domain_scores_codex":[0.9997855,0.00004066667,0.00002133437,0.00002852213,0.0001040291,0.00001994295],"domain_scores_gemma":[0.9998117,0.00006367249,0.00003293993,0.000006299508,0.00006276178,0.0000226729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001099608,0.0001466261,0.000123181,0.006145906,0.00007388547,0.0002825179,0.00004469817,0.0002142827,0.00447893,0.003570609,0.03685533,0.9479541],"study_design_scores_gemma":[0.00006959673,0.0002258059,0.0006427518,0.001444419,0.00006772839,0.0009892548,0.00003301971,0.00008475631,0.001103818,0.001567272,0.9937608,0.00001067569],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002900126,0.9953111,0.0002321672,0.0008623376,0.0003254566,0.0000100041,0.00001858529,0.000018598,0.002931832],"genre_scores_gemma":[0.001251608,0.9957446,0.0003552457,0.0005576205,0.0002837951,0.00001000688,0.00002921718,0.000002020643,0.001765857],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005567102,"threshold_uncertainty_score":0.01862383,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411195516","doi":"10.1080/14728214.2025.2517582","title":"Motor fluctuations in Parkinson disease – a mini-review of emerging drugs","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre; Toronto Western Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Parkinson's disease; Disease; Physical medicine and rehabilitation; Neuroscience; Intensive care medicine; Internal medicine; Psychology","authors":[{"name":"Priti Gros","is_ca":true},{"name":"Susan H. Fox","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03519880348203243,"gpt":0.3783357672910483,"spread":0.3431369638090159,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006993355,0.0009093583,0.001581944,0.002270067,0.0002380246,0.001119278,0.0008957693,0.001081628,0.006679092],"category_scores_gemma":[0.0009121125,0.0002801805,0.0009303644,0.001708982,0.0003537342,0.001327793,0.0006244461,0.001701489,0.002057871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005438858,"about_ca_system_score_gemma":0.001249947,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001003528,"about_ca_topic_score_gemma":0.002391427,"domain_scores_codex":[0.9997252,0.00004910423,0.00005260148,0.00004241192,0.0001040883,0.00002665088],"domain_scores_gemma":[0.9994325,0.0002879454,0.00009640611,0.00001204429,0.0001372834,0.0000338914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001107691,0.00006401856,0.0001067917,0.0538453,0.0001614787,0.000165156,0.00007054511,0.0002457495,0.000879605,0.002101577,0.04886531,0.8933836],"study_design_scores_gemma":[0.00003507679,0.0001403207,0.0006788166,0.0177325,0.0003085393,0.001124582,0.00006839472,0.0001052354,0.0001847836,0.001476902,0.9781251,0.00001962341],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005866047,0.9988291,0.00004600069,0.0002944624,0.0002564951,0.000006615093,0.00002187037,0.000004809926,0.0004820132],"genre_scores_gemma":[0.0003871428,0.9985984,0.000112569,0.0002473542,0.0002594379,0.000008179267,0.00003482731,0.000001312,0.0003507257],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006679092,"threshold_uncertainty_score":0.02234375,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4414443225","doi":"10.1080/14728214.2025.2565189","title":"Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Clinical trial; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Immunotherapy; Clinical neurology; Targeted therapy; Disease; MEDLINE","authors":[{"name":"Edgar Carnero Contentti","is_ca":false},{"name":"Vinícius Boldrini","is_ca":false},{"name":"Adriana Casallas‐Vanegas","is_ca":false},{"name":"Sanja Gluščević","is_ca":false},{"name":"Emine Rabia Koç","is_ca":false},{"name":"Sara Samadzadeh","is_ca":false},{"name":"Meral Seferoğlu","is_ca":false},{"name":"Natalia Szejko","is_ca":true},{"name":"Michael Levy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193818646769692,"gpt":0.4944612600731487,"spread":0.3750793953961795,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00678491,0.0006490329,0.002414115,0.001157609,0.0002756631,0.001780066,0.001387701,0.002358104,0.00821988],"category_scores_gemma":[0.01032383,0.0002409983,0.001642354,0.001306466,0.0006070333,0.002215735,0.0007056493,0.00276312,0.001811553],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001198348,"about_ca_system_score_gemma":0.00401293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008573372,"about_ca_topic_score_gemma":0.002430495,"domain_scores_codex":[0.9979092,0.001105957,0.0002834905,0.0001682425,0.0004359856,0.00009708274],"domain_scores_gemma":[0.9911203,0.006153001,0.0008762237,0.0001306106,0.001444708,0.0002751919],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0005709099,0.00009253703,0.0001572048,0.06635488,0.0004044333,0.0000938064,0.00007659972,0.0002970258,0.0007276054,0.005444279,0.04183401,0.8839468],"study_design_scores_gemma":[0.001005085,0.0007276887,0.0009097601,0.129758,0.001638227,0.000582926,0.0001656507,0.0003145961,0.0004536142,0.006953532,0.8574503,0.00004053461],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001501926,0.9945008,0.0001754654,0.003601277,0.0004571532,0.00004295558,0.00005276537,0.00001104753,0.001008411],"genre_scores_gemma":[0.001981927,0.9916897,0.0007136022,0.004217037,0.0006431706,0.00013345,0.0001051579,0.000007505168,0.0005084604],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9932151,"threshold_uncertainty_score":0.03588247,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4230999927","doi":"10.1517/eoed.8.2.297.21133","title":"Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Telithromycin; Ketolide; Streptococcus pneumoniae; Microbiology; Macrolide Antibiotics; Erythromycin; Efflux; Medicine; Antibiotics; Biology","authors":[{"name":"George G. Zhanel","is_ca":true},{"name":"Tamiko Hisanaga","is_ca":true},{"name":"Kim Nichol","is_ca":true},{"name":"Aleksandra Wierzbowski","is_ca":true},{"name":"Daryl J. Hoban","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05614382737932102,"gpt":0.3787878638256813,"spread":0.3226440364463603,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002550991,0.0003964142,0.0005288299,0.0004297986,0.0002184242,0.0005523991,0.0003294331,0.0008429231,0.003321412],"category_scores_gemma":[0.0001858246,0.00009190078,0.0002219444,0.0002999104,0.0002048967,0.0006198563,0.0002486484,0.0008907842,0.001675907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002984725,"about_ca_system_score_gemma":0.0003558901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003028472,"about_ca_topic_score_gemma":0.001474115,"domain_scores_codex":[0.9998933,0.00002302938,0.00001174279,0.00002045447,0.00003358802,0.00001782454],"domain_scores_gemma":[0.9999074,0.00001531255,0.00002166195,0.000004142658,0.00002763676,0.00002383531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009340173,0.0002926024,0.0008857248,0.002121514,0.00004644102,0.00142197,0.00008891527,0.0001749686,0.03800668,0.00231043,0.02518261,0.9285341],"study_design_scores_gemma":[0.0009140747,0.003390016,0.008077527,0.0006586317,0.0001870173,0.01291079,0.0001662269,0.0007296067,0.01992119,0.002114524,0.9508832,0.00004721352],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0339599,0.9325974,0.004846549,0.01096332,0.001508966,0.0001069269,0.0001895269,0.0001920485,0.01563543],"genre_scores_gemma":[0.1194561,0.8268935,0.01007837,0.008775099,0.003114985,0.0001353438,0.0005671306,0.00004297495,0.03093653],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003321412,"threshold_uncertainty_score":0.0111112,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018561236","doi":"10.1517/14728214.9.1.191","title":"Superbugs & Superdrugs: A Focus on Antibacterials – 6th Annual SMi Conference","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Emerging Drugs","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Medicine; Cephalosporin; Antibiotics; Microbiology; Biology","authors":[{"name":"N H Georgopapadakou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03002027768341804,"gpt":0.3296238282892215,"spread":0.2996035506058035,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001564467,0.001598783,0.0008598685,0.001389427,0.0006844254,0.001883497,0.0009047204,0.002780059,0.09344579],"category_scores_gemma":[0.0007919691,0.0005283917,0.0007927298,0.000602479,0.0003839135,0.001469271,0.0009602192,0.003045956,0.03270098],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001126229,"about_ca_system_score_gemma":0.001001301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000763008,"about_ca_topic_score_gemma":0.002950166,"domain_scores_codex":[0.9995364,0.00004750716,0.00001560854,0.00004585603,0.0002513493,0.000103323],"domain_scores_gemma":[0.9994701,0.00007232478,0.00003387604,0.00001784507,0.000190406,0.0002155142],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003192996,0.0001548283,0.0001095789,0.0003222468,0.00002083982,0.0001605526,0.00001646466,0.0002509186,0.01670019,0.00190532,0.7411606,0.2388792],"study_design_scores_gemma":[0.00005314909,0.0002375706,0.0004468183,0.00006490962,0.00001598009,0.0003189824,0.00001536521,0.0005830625,0.008680725,0.0006638183,0.9889036,0.00001607292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.02377029,0.2552029,0.04453808,0.1246222,0.1420161,0.001313118,0.002101091,0.006341422,0.4000949],"genre_scores_gemma":[0.03009704,0.07359916,0.01513743,0.02032857,0.01805613,0.0006114931,0.00177272,0.0007457404,0.8396518],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.09344579,"threshold_uncertainty_score":0.3126073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}